UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis

PloS one, 2019-01, Vol.14 (1), p.e0210154-e0210154

2019

Volltextzugriff (PDF)

Clinical microbiology laboratories and COVID-19: the calm before the storm

Future microbiology, 2020-10, Vol.15 (15), p.1419-1424

M Blondeau, Joseph

2020

Volltextzugriff (PDF)

Immunomodulatory Effects of Macrolides Considering Evidence from Human and Veterinary Medicine

Microorganisms (Basel), 2022-12, Vol.10 (12), p.2438

Blondeau, Joseph M

2022

Volltextzugriff (PDF)

New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach

Veterinary dermatology, 2009-10, Vol.20 (5-6), p.383-396

Blondeau, Joseph M

2009

Volltextzugriff (PDF)

Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases)

Veterinary dermatology, 2014-06, Vol.25 (3), p.163-e43

2014

Volltextzugriff (PDF)

Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6

PloS one, 2020-08, Vol.15 (8), p.e0237603-e0237603

2020

Volltextzugriff (PDF)

Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones

Journal of cataract and refractive surgery, 2010-09, Vol.36 (9), p.1588-1598

2010

Volltextzugriff (PDF)

Comparative Minimum Inhibitory and Mutant Prevention Drug Concentrations for Pradofloxacin and Seven Other Antimicrobial Agents Tested against Bovine Isolates of Mannheimia haemolytica and Pasteurella multocida

Pathogens (Basel), 2024-05, Vol.13 (5), p.399

2024

Volltextzugriff (PDF)

Comparative In Vitro Killing by Pradofloxacin in Comparison to Ceftiofur, Enrofloxacin, Florfenicol, Marbofloxacin, Tildipirosin, Tilmicosin and Tulathromycin against Bovine Respiratory Bacterial Pathogens

Microorganisms (Basel), 2024-05, Vol.12 (5), p.996

2024

Volltextzugriff (PDF)

In Vitro Killing of Canine Urinary Tract Infection Pathogens by Ampicillin, Cephalexin, Marbofloxacin, Pradofloxacin, and Trimethoprim/Sulfamethoxazole

Microorganisms (Basel), 2021-11, Vol.9 (11), p.2279

2021

Volltextzugriff (PDF)

Antimicrobial Use Guidelines for Treatment of Urinary Tract Disease in Dogs and Cats : Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases

Veterinary medicine international, 2011, Vol.2011 (2011), p.1-9

2011

Volltextzugriff (PDF)

Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy, 2001-02, Vol.45 (2), p.433-438

2001

Volltextzugriff (PDF)

So we now have RSV vaccines. What's our next steps?

Expert review of respiratory medicine, 2024, Vol.18 (1-2), p.17-22

Blondeau, Joseph M

2024

Volltextzugriff (PDF)

Recovery of Vandammella animalimorsus from an immunocompetent female patient following cat bite to the lower leg

Future microbiology, 2024-08, Vol.19 (12), p.1049-1054

2024

Volltextzugriff (PDF)

Has coronavirus disease 2019 changed clinical microbiology laboratories forever?

Future microbiology, 2023-11, Vol.18 (17), p.1211-1215

2023

Volltextzugriff (PDF)

Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report

Future microbiology, 2017-12, Vol.12 (16), p.1523-1532

2017

Volltextzugriff (PDF)

Tetrasodium EDTA Is Effective at Eradicating Biofilms Formed by Clinically Relevant Microorganisms from Patients' Central Venous Catheters

mSphere, 2018-11, Vol.3 (6)

2018

Volltextzugriff (PDF)

In vitro killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation

Journal of chemotherapy (Florence), 2024-09, Vol.36 (5), p.389-397

2024

Volltextzugriff (PDF)

Fluoroquinolones: mechanism of action, classification, and development of resistance

Survey of ophthalmology, 2004-03, Vol.49 (2), p.S73-S78

Blondeau, Joseph M.

2004

Volltextzugriff (PDF)

Zoonotic Staphylococcus pseudintermedius : an underestimated human pathogen?

Future microbiology, 2023-04, Vol.18 (6), p.311-315

2023

Volltextzugriff (PDF)

Antimicrobial resistance & 'Man's best friend': what they give to us we might be giving right back

Future microbiology, 2017-06, Vol.12 (7), p.549-553

Blondeau, Joseph M

2017

Volltextzugriff (PDF)

Microbiological analysis of tunneled hemodialysis catheters isolated from patients receiving hemodialysis in Saskatchewan

Future microbiology, 2024-09, Vol.19 (13), p.1129

2024

Volltextzugriff (PDF)

The 24-h clinical microbiology service is essential for patient management

Future microbiology, 2018-11, Vol.13 (15), p.1625-1628

2018

Volltextzugriff (PDF)

Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (Suppl 4), p.iv32-iv38

2019

Volltextzugriff (PDF)

In vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefazolin, cefovecin, doxycycline and pradofloxacin over a range of bacterial densities

Veterinary dermatology, 2020-06, Vol.31 (3), p.187-e39

2020

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(76)

Publikationsform

Sprache

Englisch
(109)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(76)
Humans
(57)
Microbiology
(35)
Pharmacology & Pharmacy
(29)
Microbial Sensitivity Tests
(26)
Animals
(25)
Infectious Diseases
(25)
Anti-Bacterial Agents - Pharmacology
(24)
Biological And Medical Sciences
(20)
Female
(18)
Medical Sciences
(18)
Anti-Bacterial Agents - Therapeutic Use
(16)
Bacteria
(16)
Antibiotics
(14)
Laboratories
(13)
Anti-Infective Agents - Pharmacology
(12)
Fluoroquinolones
(12)
Fluoroquinolones - Pharmacology
(12)
Antimicrobial Agents
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Mutant prevention and minimum inhibitory concentration drug values for enrofloxacin, ceftiofur, florfenicol, tilmicosin and tulathromycin tested against swine pathogens Actinobacillus pleuropneumoniae, Pasteurella multocida and Streptococcus suis

Clinical microbiology laboratories and COVID-19: the calm before the storm

Immunomodulatory Effects of Macrolides Considering Evidence from Human and Veterinary Medicine

New concepts in antimicrobial susceptibility testing: the mutant prevention concentration and mutant selection window approach

Guidelines for the diagnosis and antimicrobial therapy of canine superficial bacterial folliculitis (Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases)

Characterization of baseline polybacterial versus monobacterial infections in three randomized controlled bacterial conjunctivitis trials and microbial outcomes with besifloxacin ophthalmic suspension 0.6

Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones

Comparative Minimum Inhibitory and Mutant Prevention Drug Concentrations for Pradofloxacin and Seven Other Antimicrobial Agents Tested against Bovine Isolates of Mannheimia haemolytica and Pasteurella multocida

Comparative In Vitro Killing by Pradofloxacin in Comparison to Ceftiofur, Enrofloxacin, Florfenicol, Marbofloxacin, Tildipirosin, Tilmicosin and Tulathromycin against Bovine Respiratory Bacterial Pathogens

In Vitro Killing of Canine Urinary Tract Infection Pathogens by Ampicillin, Cephalexin, Marbofloxacin, Pradofloxacin, and Trimethoprim/Sulfamethoxazole

Antimicrobial Use Guidelines for Treatment of Urinary Tract Disease in Dogs and Cats : Antimicrobial Guidelines Working Group of the International Society for Companion Animal Infectious Diseases

Mutant Prevention Concentrations of Fluoroquinolones for Clinical Isolates of Streptococcus pneumoniae

So we now have RSV vaccines. What's our next steps?

Recovery of Vandammella animalimorsus from an immunocompetent female patient following cat bite to the lower leg

Has coronavirus disease 2019 changed clinical microbiology laboratories forever?

Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report

Tetrasodium EDTA Is Effective at Eradicating Biofilms Formed by Clinically Relevant Microorganisms from Patients' Central Venous Catheters

In vitro killing of drug susceptible and multidrug resistant bacteria by amikacin considering pulmonary drug concentrations based on an inhaled formulation

Fluoroquinolones: mechanism of action, classification, and development of resistance

Zoonotic Staphylococcus pseudintermedius : an underestimated human pathogen?

Antimicrobial resistance & 'Man's best friend': what they give to us we might be giving right back

Microbiological analysis of tunneled hemodialysis catheters isolated from patients receiving hemodialysis in Saskatchewan

The 24-h clinical microbiology service is essential for patient management

Characterization of carbapenem-resistant and XDR Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-16 study

In vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefazolin, cefovecin, doxycycline and pradofloxacin over a range of bacterial densities

Suchergebnisse filtern